LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

LLY

1,070.32

-0.45%↓

JNJ

205.85

-0.71%↓

ABBV

228.65

+0.42%↑

UNH

324.98

-0.04%↓

AZN

92.05

+0.56%↑

Home・Aktien・Vivani Medical

Vivani Medical

Geschlossen

1.35 -4.26

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.35

Max

1.4

Schlüsselkennzahlen
By Trading Economics
Angestellte	37

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+187.77% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-15M 89M
Vorheriger Eröffnungskurs	5.61
Vorheriger Schlusskurs	1.35

Vivani Medical Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Dez. 2025, 23:54 UTC

Wichtige Markttreiber

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

22. Dez. 2025, 19:08 UTC

Akquisitionen, Fusionen, Übernahmen

Correction to Alphabet to Buy Intersect Article

22. Dez. 2025, 17:21 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

22. Dez. 2025, 16:46 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75 Billion in Cash

22. Dez. 2025, 23:50 UTC

Market Talk

Nikkei May Decline as Yen Rebounds -- Market Talk

22. Dez. 2025, 23:42 UTC

Market Talk

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

22. Dez. 2025, 22:31 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

22. Dez. 2025, 22:31 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

22. Dez. 2025, 22:30 UTC

Ergebnisse

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

22. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Dez. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

22. Dez. 2025, 21:37 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

22. Dez. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

22. Dez. 2025, 21:35 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn to Acquire Prospective Package From Tempest Minerals

22. Dez. 2025, 21:35 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

22. Dez. 2025, 20:54 UTC

Akquisitionen, Fusionen, Übernahmen

Middle West Partners Buys Paul Stuart From Mitsui & Co.

22. Dez. 2025, 20:52 UTC

Akquisitionen, Fusionen, Übernahmen

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

22. Dez. 2025, 20:09 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

22. Dez. 2025, 19:56 UTC

Market Talk

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

22. Dez. 2025, 19:49 UTC

Akquisitionen, Fusionen, Übernahmen

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

22. Dez. 2025, 19:23 UTC

Market Talk

Mexico's Inflation Seen Easing in Early December -- Market Talk

22. Dez. 2025, 19:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. Dez. 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

22. Dez. 2025, 19:02 UTC

Market Talk

Precious Metals Climb to New Heights -- Market Talk

22. Dez. 2025, 18:45 UTC

Market Talk

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

22. Dez. 2025, 18:30 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

22. Dez. 2025, 18:23 UTC

Akquisitionen, Fusionen, Übernahmen

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

22. Dez. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

22. Dez. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

22. Dez. 2025, 17:06 UTC

Akquisitionen, Fusionen, Übernahmen

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

Peer-Vergleich

Kursveränderung

Vivani Medical Prognose

Kursziel

By TipRanks

187.77% Vorteil

12-Monats-Prognose

Durchschnitt 4 USD 187.77%

Hoch 4 USD

Tief 4 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Vivani Medical – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Vivani Medical – Dist abgegeben haben.

Finanzen

Über Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.